Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by Camaronion May 27, 2011 11:16am

275 Views

Post# 18634541

Somebody Obviously Trying to Keep Price Down

Can't be much more obvious than that. Small lot, early and well below open. The woes of thinly traded stock.

10:17:40	V	0.28	0.04	15,000	80 National Bank	19 Desjardins	K
10:15:45	V	0.28	0.04	5,000	80 National Bank	19 Desjardins	K
10:15:09	V	0.28	0.04	9,000	80 National Bank	19 Desjardins	K
10:14:47	V	0.28	0.04	15,000	80 National Bank	7 TD Sec	K
10:14:47	V	0.28	0.04	1,000	80 National Bank	19 Desjardins	K
09:53:01	V	0.235	-0.005	500	79 CIBC	124 Questrade	K
09:30:37	V	0.28	0.04	5,000	19 Desjardins	19 Desjardins	KL